BOEHRINGER-INGELHEIM PHILS., INC.
Boehringer Ingelheim Phils or BIPHI is one of the leading pharmaceutical company in the Philippines. Boehringer Ingelheim Phils Inc was established in 1962 as C.H. Boeringer Sohn , a divison of Muller and Phipps and began operation in January 1963 with 8 employees. It was officially incorporated in December 7, 1966 and was housed in Mandaluyong, Don Jacinto Bldg. in Makati and transferred to Citibank Tower in 1994. Boehringer Ingelheim Phils Inc is a subsidiary of Boehringer Ingelheim GmBH, the largest privately held pharmaceutical company in the world.
The company offers Prescriprion Medicine, Consumer Healthcare and Animal Health products. The company has been committed to researching, developing, manufacturing products for respiratory disease, cardiovascular disease, Parkinson’s disease, HIV and thrombeolic disease. Our prescription products include Micardis, Twynsta, Pradaxa, Spiriva, Combivent, Mobic, Sifrol & Mucosolvan. Our core products for Consumer Healthcare are Bisolvon, Buscopan, Dulcolax, Pharmaton and Pharmaton Kiddi. The company also offers swine vaccine for Animal Health.
Bisolvon, hailed as a miracle product, has been a trusted family cough medicine of choice. Mucosolvan , also a cough medicine was a big success allowing BIPHI to land in the top 5 drug companies
To date, BIPHI employs a total of 365 personnel, and continues to grow in response to the demands of the market and the future. Our products are distributed by Metro Drug, Inc and manufactured by Interphil. It has been in the Philippines for 44 years. Boehringer Ingelheim Phil Inc ranks # 8 in the market.